Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps
about
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitisShort-course oral steroids alone for chronic rhinosinusitisSaline irrigation for chronic rhinosinusitisSystemic and topical antibiotics for chronic rhinosinusitisDifferent types of intranasal steroids for chronic rhinosinusitisShort-course oral steroids as an adjunct therapy for chronic rhinosinusitisShort-course oral steroids as an adjunct therapy for chronic rhinosinusitisSaline irrigation for chronic rhinosinusitisShort-course oral steroids alone for chronic rhinosinusitisSystemic and topical antibiotics for chronic rhinosinusitisDifferent types of intranasal steroids for chronic rhinosinusitisIntranasal steroids versus placebo or no intervention for chronic rhinosinusitisIL-32θ negatively regulates IL-1β production through its interaction with PKCδ and the inhibition of PU.1 phosphorylationIL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino SinusitisInterleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues.Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.ICON: chronic rhinosinusitis.Elevated interleukin-32 expression is associated with Helicobacter pylori-related gastritis.Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit.Gene expression signatures: a new approach to understanding the pathophysiology of chronic rhinosinusitis.Role of interleukin-32 in chronic rhinosinusitisInterleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.Cytokine Patterns and Endotypes in Acute and Chronic Rhinosinusitis.International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.Assessment of epithelial innate antimicrobial factors in sinus tissue from patients with and without chronic rhinosinusitis.Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.c-Jun N-terminal kinase and Akt signalling pathways regulating tumour necrosis factor-α-induced interleukin-32 expression in human lung fibroblasts: implications in airway inflammation.Expression of Clara cell 10-kDa protein and trefoil factor family 1 in patients with chronic rhinosinusitis and nasal polyps.Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities.Toll-like receptor 4-mediated expression of interleukin-32 via the c-Jun N-terminal kinase/protein kinase B/cyclic adenosine monophosphate response element binding protein pathway in chronic rhinosinusitis with nasal polyps.The Biology and Role of Interleukin-32 in TuberculosisIL-32γ attenuates airway fibrosis by modulating the integrin-FAK signaling pathway in fibroblastsTopical and systemic antifungal therapy for chronic rhinosinusitis
P2860
Q24185859-E777F4B4-4514-4F0B-B438-6EECDA554348Q24185860-D1274935-9CDD-4252-985C-329292FFF228Q24185862-CB360026-C895-4D40-A228-B98746773115Q24185864-CFC97696-343D-4560-92AC-4C1142EE279CQ24185865-0DD35B84-013F-47D8-90AF-DA8F5305EA23Q24185867-7ECFEFA5-3B42-4775-96F8-60271EC0F0AAQ24187421-A6EA8E34-746C-483C-8BA4-17A436F3587FQ24187461-D36D3656-02F0-4110-AEA9-0A46C2DBA21AQ24187464-5D7A1C80-8AA6-4952-82D9-66FA83C1B3BDQ24187471-A02FE9AE-D5B1-4009-887F-2617956FF0DBQ24187477-F20DBB9F-C730-4286-8F60-B2CA8AFC3128Q24187482-B0D62916-9B0E-4A22-8776-CB45E1CCFCBAQ24300286-8B21856D-45A6-4E2F-9FA5-71D72FEA99D1Q26753017-2ACD7C3C-0C7B-405F-8DD6-AC1AECFF2992Q33633481-34FE243D-7DAF-462C-8BB3-6E02EE57110EQ34042748-6CC477A6-BEA1-4B1F-8A2C-02D6B801B9D7Q34165569-54641C2F-82B1-476F-B02B-5E097A05FD53Q34423484-74D2C8E4-D160-489D-96D4-EFA1D9D0C2B8Q35122065-C4B4D38B-52EF-4CD1-9B6A-F78CB1D77996Q38024866-4DDE980D-A06B-4554-AD88-ECD6E1465790Q38066113-30AEEA16-1329-4BFC-8687-2CE6297BB530Q38067583-D89CD2FB-81F2-4546-8F0C-ADED6D54361BQ38443719-8BB2072F-6925-436F-807D-1EB877761B17Q38680311-DC6782F3-2B3B-4F2A-8724-10029BDF2D35Q38738551-CB6B5075-19E8-4EDE-8EC4-046D2D61AFE7Q41874032-FBA10C25-913B-4F62-81BF-275AD42BC568Q42236150-CAC74C43-3935-40F6-AA99-23C57F6B6200Q42464535-267CBA7B-939D-4B6B-91B5-AA440C5E14A8Q49809512-A3D615F8-D045-4821-9FC1-A4C7FF6B7217Q51536953-398AFCE0-C594-42E1-9C63-03F8B1ECECE3Q52643512-0584761D-18D8-4712-9ECE-1B67F3828119Q53100844-3F3A6949-67AE-41AC-80E6-3AC0014A4C67Q58694023-0047AC38-4D8A-44BA-898C-715F1157D236Q58694819-6D244D1C-B745-45E3-9D06-AD84F6751BA2Q59154670-5E59A8B9-2C60-48AE-AC46-6BB085FB58D9
P2860
Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Differential expression of int ...... with and without nasal polyps
@ast
Differential expression of int ...... with and without nasal polyps
@en
type
label
Differential expression of int ...... with and without nasal polyps
@ast
Differential expression of int ...... with and without nasal polyps
@en
prefLabel
Differential expression of int ...... with and without nasal polyps
@ast
Differential expression of int ...... with and without nasal polyps
@en
P2093
P2860
P1433
P1476
Differential expression of int ...... with and without nasal polyps
@en
P2093
A T Peters
C A Dinarello
R P Schleimer
P2860
P356
10.1111/J.1398-9995.2011.02706.X
P577
2011-09-07T00:00:00Z